Hikma Pharmaceuticals (HIK)

Sector: Pharma and Biotech     Index: FTSE 250
1.37%
16.00p
1,188.00p
17:25 22/08/17
1,188.00p
17:25 22/08/17
DAILY VARIATION
1.37%
16.00p
VOLUME
1,126,336
REAL TIME BATS
1,193.00p
17:36 22/08/17
2.14%
25.00p
DATA
52 Week High
2,303.00p
52 Week Low
1,119.00p
Shares Issued
240.65m
Market Cap
£2,858.89m
RiskGrade
n/a
Beta
1.37
MENU

Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 2.2% 2.1%
Div Cover 3.6 3.6
Op Mrgn 15.5% 15.7%
ROCE 19.3%
Latest F'cast
P/E 12.9 14.2
PEG -0.7 -1.5
Pr/Revenue 1.9 1.7
Pr/Book 1.5
Latest F'cast
Revenue 35.4% -12.1%
PBT -34.0% n/a
EPS -17.5% -31.0%
DPS 3.1% -9.2%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,109.00 132.00 61.40¢ 20.2 1.1 18% 16.00¢ 1.3%
2013-12-31 1,365.00 298.00 139.10¢ 14.3 0.1 127% 20.00¢ 1.0%
2014-12-31 1,489.00 362.00 151.00¢ 20.4 2.4 9% 22.00¢ 0.7%
2015-12-31 1,440.00 318.00 143.70¢ 23.6 -4.9 -5% 32.00¢ 0.9%
2016-12-31 1,950.00 210.00 118.50¢ 19.7 -1.1 -18% 33.00¢ 1.4%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 1,565.04 246.24 80.79p 14.2 -1.2 -12% 22.70p 2.0%
2018-12-31 1,677.00 313.41 100.10p 11.3 0.5 24% 25.45p 2.3%

Regulatory News

slide to see more
Half-year Report 17-Aug-17 07:04
Director/PDMR Shareholding 10-Aug-17 10:05
Director/PDMR Shareholding 10-Aug-17 10:03